Recent Advancements in Antimycobacterial and Antifungal Drugs: A Patent Perspective

Area of Science:

• Microbiology
• Pharmacology
• Drug Discovery

Background:

• Rising incidence of Mycobacterium and fungal infections globally.
• Increased mortality rates in immunocompromised patients due to these infections.
• Growing multidrug resistance and severe toxicity of current antimicrobial drugs.

Purpose of the Study:

• To identify novel, safer, and more effective antimicrobial drugs.
• To explore natural bioactive compounds and synthetically derived drugs for therapeutic potential.
• To address the limitations of existing treatments for bacterial and fungal infections.

Main Methods:

• Review of current literature on antimicrobial drug development.
• Focus on natural compounds and synthetic drugs targeting the cell envelope.
• Identification of patentable therapeutic interventions.

Main Results:

• Summary of available natural and synthetic drugs against bacterial and fungal pathogens.
• Highlighting therapeutic interventions with potential for patenting.
• Overview of drugs targeting the cell envelope of pathogens.

Conclusions:

• Urgent need for new antimicrobial agents due to resistance and toxicity.
• Natural products and synthetic chemistry offer promising avenues for drug discovery.
• Development of novel drugs targeting the cell envelope is crucial for combating prevalent infections.